Sustainable Access to Diagnostics & Therapeutics for HBV - John C. Rwegasha,MBChB, MMED, FRCP (Lond), MSc

Conference on Liver Disease in Africa (COLDA) 2023

HCV: Effect of Reinfection on Elimination - Importance of Self Testing - Janvier Serumondo, MD, MPH, MTM

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis E Virus Detected in Wastewater Samples in South Africa

Conference on Liver Disease in Africa (COLDA) 2023

Time to Initiation of Hepatitis B Treatment Is Reduced with the Use of the Xpert HBV DNA Kit

Conference on Liver Disease in Africa (COLDA) 2023

A Hepatitis B Virus Dual Point-of-Care Test Strategy to Identify Treatment-Eligible Patients in Africa

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B (HBV) Testing and Treatment Policy Assessment in Six African Countries: Examples to Inform HBV Program Scale-Up

Conference on Liver Disease in Africa (COLDA) 2023

Hepatitis B Virus Genotypes - Anna Kramvis, BSc Hons, PhD

Conference on Liver Disease in Africa (COLDA) 2023

Barriers to Implementation/Access to Care - Danjuma K. Adda, MPH, FIMS, Dip-IMS

Conference on Liver Disease in Africa (COLDA) 2023

WHO HBV Guidelines - New Directions for Hepatitis B Treatment and Care and Implications for Africa - Philippa Easterbrook, MD, FRCP, MPH, DTM&H

Conference on Liver Disease in Africa (COLDA) 2023

African CDC - Growing Portfolio of Hepatitis-Related Activities - Hanna Amanuel Tesfahunei, MSc

Conference on Liver Disease in Africa (COLDA) 2023

United Nations Group of Friends to Eliminate Hepatitis - John Ward, MD

Conference on Liver Disease in Africa (COLDA) 2023

Endogeneous Retroviruses and Inflammation - Yasmine Belkaid, PhD

Viral Infections & Inflammation Workshop 2023

Summary Video for Clinicians - Roger Paredes, PhD

Viral Infections & Inflammation Workshop 2023

Inflammasome Activation in Severe Cases of COVID-19 - Dario Zamboni, PhD

Viral Infections & Inflammation Workshop 2023

Developing CAR T Cells for Use in Chronic HIV Infection - Martin Tolstrup, MSc, PhD

Viral Infections & Inflammation Workshop 2023

The Plasma Microbiome Contributes to Immune Reconstitution in HIV Infected Individuals on Suppressive ART - Wei Jiang

Viral Infections & Inflammation Workshop 2023

HIV, Inflammation, and Macrophages - Maureen M. Goodenow, PhD

Viral Infections & Inflammation Workshop 2023

Possible Role of Intestinal Damage and Endotoxemia in the Development of Endotholial Dysfunction, Thrombosis and Secondary Lung Damage in Patients with COVID-19 - Liudmyla Shostakovych-Koretskaya

Viral Infections & Inflammation Workshop 2023

HIV Exposed Uninfected (Heu) Infants Have Pro-inflammatory Bioprofiles That Correlate with Their Mothers’ Bioprofiles Independent of Viral Levels and Persist for at Least Six Months - Li Yin

Viral Infections & Inflammation Workshop 2023

Post-acute Sequelae following Ebola infection - David Wohl, MD

Viral Infections & Inflammation Workshop 2023

What We Know Now about HIV and Long COVID - Annie Antar, MD, PhD

Viral Infections & Inflammation Workshop 2023

Epstein–Barr Virus and Multiple Sclerosis: Which Mechanisms are at Play? - Tobias Lanz, MD

Viral Infections & Inflammation Workshop 2023

Immunopathology of viral encephalitis - Avindra Nath, MD

Viral Infections & Inflammation Workshop 2023

Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Cohort Study - Roger Paredes, PhD

Viral Infections & Inflammation Workshop 2023